New Site Metrix Helps Pharma Inform Clinical Trial Plans
KMR Group announces its newest release of Site Metrix Application which provides clinical site performance benchmarks to the biopharma industry. The application will be used to help biopharma in the performance evaluation of their sites and set realistic site level enrollment plans. Accessing this data will no longer pose a challenge as well.
Read the full release here.
HHS Cancels Moderna Grant for Late-Stage Development of mRNA Vaccine Candidate
June 4th 2025Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s award for almost $600 million to accelerate vaccine development will be terminated.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
America’s Vanishing Scientific Research Workforce is a Threat to Public Health
June 2nd 2025As biotech innovation accelerates, the clinical research workforce is rapidly eroding—threatening the future of drug development. From workforce burnout to training program cuts and talent pipeline collapse, clinical trial professionals must confront this escalating crisis head-on to sustain progress and protect public health.
